Search by Drug Name or NDC
NDC 55154-7353-02 Sodium Polystyrene Sulfonate 15 g/60mL Details
Sodium Polystyrene Sulfonate 15 g/60mL
Sodium Polystyrene Sulfonate is a ORAL; RECTAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cardinal Health 107, LLC. The primary component is SODIUM POLYSTYRENE SULFONATE.
MedlinePlus Drug Summary
Sodium polystyrene sulfonate is used to treat hyperkalemia (increased amounts of potassium in the body). Sodium polystyrene sulfonate is in a class of medications called potassium-removing agents. It works by removing excess potassium from the body.
Related Packages: 55154-7353-02Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Sodium Polystyrene Sulfonate
Product Information
NDC | 55154-7353 |
---|---|
Product ID | 55154-7353_ae3163a2-d8ea-4735-bc5f-e74c83d5dcac |
Associated GPIs | 99450010001840 |
GCN Sequence Number | 076420 |
GCN Sequence Number Description | sodium polystyrene sulfon/sorb ORAL SUSP 15 G/60 ML ORAL |
HIC3 | C1A |
HIC3 Description | ELECTROLYTE DEPLETERS |
GCN | 41955 |
HICL Sequence Number | 043638 |
HICL Sequence Number Description | SODIUM POLYSTYRENE SULFONATE/SORBITOL SOLUTION |
Brand/Generic | Generic |
Proprietary Name | Sodium Polystyrene Sulfonate |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | sodium polystyrene sulfonate |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | SUSPENSION |
Route | ORAL; RECTAL |
Active Ingredient Strength | 15 |
Active Ingredient Units | g/60mL |
Substance Name | SODIUM POLYSTYRENE SULFONATE |
Labeler Name | Cardinal Health 107, LLC |
Pharmaceutical Class | n/a |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA087859 |
Listing Certified Through | 2024-12-31 |
Package
NDC 55154-7353-02 (55154735302)
NDC Package Code | 55154-7353-2 |
---|---|
Billing NDC | 55154735302 |
Package | 2 BOTTLE, UNIT-DOSE in 1 BAG (55154-7353-2) / 60 mL in 1 BOTTLE, UNIT-DOSE |
Marketing Start Date | 1983-01-01 |
NDC Exclude Flag | N |
Pricing Information | N/A |